| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2013
|
12.73
|
|
2
|
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
|
Eur Heart J
|
2013
|
9.54
|
|
3
|
Guidelines on myocardial revascularization.
|
Eur Heart J
|
2010
|
8.85
|
|
4
|
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
|
Eur Heart J
|
2013
|
6.17
|
|
5
|
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
|
Eur Heart J
|
2013
|
5.23
|
|
6
|
Guidelines on myocardial revascularization.
|
Eur J Cardiothorac Surg
|
2010
|
3.47
|
|
7
|
Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope.
|
Eur Heart J
|
2005
|
2.84
|
|
8
|
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
|
Eur Heart J
|
2016
|
2.09
|
|
9
|
Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups.
|
Crit Care Med
|
2005
|
1.99
|
|
10
|
Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease.
|
Circulation
|
2008
|
1.84
|
|
11
|
Cardiac rehabilitation in Europe: results from the European Cardiac Rehabilitation Inventory Survey.
|
Eur J Cardiovasc Prev Rehabil
|
2010
|
1.71
|
|
12
|
Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation.
|
Circulation
|
2002
|
1.67
|
|
13
|
Secondary prevention through cardiac rehabilitation: physical activity counselling and exercise training: key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.
|
Eur Heart J
|
2010
|
1.46
|
|
14
|
2016 European Guidelines on cardiovascular disease prevention in clinical practice.
|
Rev Esp Cardiol (Engl Ed)
|
2016
|
1.42
|
|
15
|
Exercise Performance Is a Prognostic Indicator in Elderly Patients With Chronic Heart Failure - Application of Metabolic Exercise Cardiac Kidney Indexes Score.
|
Circ J
|
2015
|
1.42
|
|
16
|
Exercise training reverses exertional oscillatory ventilation in heart failure patients.
|
Eur Respir J
|
2012
|
1.40
|
|
17
|
Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption.
|
Int J Cardiol
|
2013
|
1.40
|
|
18
|
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part II: How to perform cardiopulmonary exercise testing in chronic heart failure.
|
Eur J Cardiovasc Prev Rehabil
|
2006
|
1.21
|
|
19
|
Muscle metaboreflex-induced increases in stroke volume.
|
Med Sci Sports Exerc
|
2003
|
1.18
|
|
20
|
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation. Part I: definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure.
|
Eur J Cardiovasc Prev Rehabil
|
2006
|
1.14
|
|
21
|
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
|
Eur J Prev Cardiol
|
2016
|
1.07
|
|
22
|
Adherence of heart failure patients to exercise: barriers and possible solutions: a position statement of the Study Group on Exercise Training in Heart Failure of the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
|
2012
|
1.04
|
|
23
|
Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links.
|
Cardiovasc Res
|
2006
|
1.04
|
|
24
|
Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure.
|
J Am Coll Cardiol
|
2006
|
1.03
|
|
25
|
Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival.
|
Circulation
|
2006
|
1.00
|
|
26
|
Chemical mediators of the muscle ergoreflex in chronic heart failure: a putative role for prostaglandins in reflex ventilatory control.
|
Circulation
|
2002
|
0.98
|
|
27
|
Skeletal muscle reflex in heart failure patients: role of hydrogen.
|
Circulation
|
2003
|
0.94
|
|
28
|
Differential contribution of dead space ventilation and low arterial pCO2 to exercise hyperpnea in patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
|
Am J Cardiol
|
2004
|
0.92
|
|
29
|
Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones.
|
J Cachexia Sarcopenia Muscle
|
2014
|
0.92
|
|
30
|
Chemo- and ergoreflexes in health, disease and ageing.
|
Int J Cardiol
|
2005
|
0.92
|
|
31
|
Prediction of mortality in chronic heart failure from peak oxygen consumption adjusted for either body weight or lean tissue.
|
J Card Fail
|
2004
|
0.90
|
|
32
|
Cardiothoracic ratio from postero-anterior chest radiographs: a simple, reproducible and independent marker of disease severity and outcome in adults with congenital heart disease.
|
Int J Cardiol
|
2011
|
0.88
|
|
33
|
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2016
|
0.88
|
|
34
|
Anemia in adults with congenital heart disease relates to adverse outcome.
|
J Am Coll Cardiol
|
2009
|
0.87
|
|
35
|
2016 Focused Update: Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations.
|
Circulation
|
2016
|
0.85
|
|
36
|
Reproducible efficacy of loading oral propafenone in restoring sinus rhythm in patients with paroxysmal atrial fibrillation.
|
Am J Cardiol
|
2003
|
0.85
|
|
37
|
Can level of education, accreditation and use of databases in cardiac rehabilitation be improved? Results from the European Cardiac Rehabilitation Inventory Survey.
|
Eur J Prev Cardiol
|
2011
|
0.84
|
|
38
|
Healthy lifestyle interventions to combat noncommunicable disease-a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine.
|
Eur Heart J
|
2015
|
0.84
|
|
39
|
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
|
Atherosclerosis
|
2016
|
0.83
|
|
40
|
Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure.
|
Eur Heart J
|
2004
|
0.83
|
|
41
|
Excessive ventilation during early phase of exercise: a new predictor of poor long-term outcome in patients with chronic heart failure.
|
Eur J Heart Fail
|
2007
|
0.82
|
|
42
|
Resting lung function in the assessment of the exercise capacity in patients with chronic heart failure.
|
Am J Med Sci
|
2010
|
0.82
|
|
43
|
The 'skeletal muscle hypothesis in heart failure' revised.
|
Eur Heart J
|
2013
|
0.82
|
|
44
|
Out-of-hospital early defibrillation successfully challenges sudden cardiac arrest: the Piacenza Progetto Vita project.
|
Ital Heart J
|
2002
|
0.81
|
|
45
|
Hyponatraemia: A strong predictor of mortality in adults with congenital heart disease.
|
Eur Heart J
|
2009
|
0.81
|
|
46
|
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
|
2016
|
0.81
|
|
47
|
Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.
|
Int J Cardiol
|
2012
|
0.80
|
|
48
|
Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure.
|
Eur J Heart Fail
|
2003
|
0.79
|
|
49
|
Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients.
|
Eur Heart J
|
2008
|
0.79
|
|
50
|
Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis.
|
Eur J Heart Fail
|
2005
|
0.78
|
|
51
|
Official document on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction--recommendations for performance and interpretation.
|
Monaldi Arch Chest Dis
|
2007
|
0.78
|
|
52
|
[Standards and outcome measures in cardiovascular rehabilitation. Position paper GICR/IACPR].
|
Monaldi Arch Chest Dis
|
2012
|
0.78
|
|
53
|
Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria.
|
Eur J Heart Fail
|
2013
|
0.78
|
|
54
|
[The walking test: use in clinical practice].
|
Monaldi Arch Chest Dis
|
2009
|
0.77
|
|
55
|
Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Recommendations for performance and interpretation.
|
Eur J Cardiovasc Prev Rehabil
|
2006
|
0.77
|
|
56
|
[Telecardiology: perspectives and limitations].
|
Ital Heart J Suppl
|
2004
|
0.77
|
|
57
|
Exercise intolerance in adults with congenital heart disease.
|
Cardiol Clin
|
2006
|
0.77
|
|
58
|
Healthy Lifestyle Interventions to Combat Noncommunicable Disease—A Novel Nonhierarchical Connectivity Model for Key Stakeholders: A Policy Statement From the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine.
|
Mayo Clin Proc
|
2015
|
0.76
|
|
59
|
Age-related reflex responses from peripheral and central chemoreceptors in healthy men.
|
Clin Auton Res
|
2014
|
0.76
|
|
60
|
Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.
|
Eur J Heart Fail
|
2014
|
0.76
|
|
61
|
Aerobic exercise physiology in a professional rugby union team.
|
Int J Cardiol
|
2003
|
0.76
|
|
62
|
Immune activation and inflammatory system in chronic heart failure: novel pathophysiological hypotheses generate new therapeutic options.
|
Int J Clin Pract
|
2007
|
0.75
|
|
63
|
Cardiovascular variability is/is not an index of autonomic control of circulation.
|
J Appl Physiol (1985)
|
2006
|
0.75
|
|
64
|
Exercise rehabilitation in heart disease: the real "polypill" for primary and secondary prevention.
|
Monaldi Arch Chest Dis
|
2005
|
0.75
|
|
65
|
Heart rate turbulence in adults with repaired tetralogy of Fallot.
|
Int J Cardiol
|
2008
|
0.75
|
|
66
|
"Rehabilitation" after PCI: nonsense or the only way to achieve lasting results?
|
EuroIntervention
|
2010
|
0.75
|
|
67
|
Attenuated autonomic function in multiple organ dysfunction syndrome across three age groups.
|
Biomed Tech (Berl)
|
2006
|
0.75
|
|
68
|
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches.
|
Curr Pharm Des
|
2016
|
0.75
|
|
69
|
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].
|
G Ital Cardiol (Rome)
|
2017
|
0.75
|
|
70
|
Exercise in heart failure patients: why and how should nurses care?
|
Eur J Cardiovasc Nurs
|
2014
|
0.75
|
|
71
|
[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines].
|
Kardiol Pol
|
2016
|
0.75
|
|
72
|
Ventricular assist device patients on the horizon of cardiovascular prevention and rehabilitation. Can we convert challenges into opportunities?
|
Eur J Prev Cardiol
|
2012
|
0.75
|
|
73
|
Prognostic value of indeterminable anaerobic threshold in heart failure.
|
Circ Heart Fail
|
2013
|
0.75
|
|
74
|
Cardiostin 2002.
|
Heart Fail Monit
|
2002
|
0.75
|
|
75
|
Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern.
|
Am J Cardiol
|
2003
|
0.75
|